Single tablet regimen vs atazanavir, ritonavir and Truvada for treatment of HIV-1 in treatment-naive women

What we are studying

Compare dolutegravir/abacavir/lamivudine (experimental) versus atazanavir plus ritonavir plus Truvada (all FDA approved) for the treatment of HIV in women who have never taken antiretroviral medications

Who we are studying

  • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • HIV viral load greater than 500
  • Not pregnant or breastfeeding
  • Not infected with Hepatitis B or C

What is involved

  • 2 - 7 study visits
  • 4 phone calls
  • Physical exams
  • Electrocardiogram
  • Blood draws
  • Urine collection
  • Questionnaires

Contact Information

Study Coordinator
Liby Mosley
Email
limosley@wakehealth.edu
Phone
336-716-3266
Principal Investigator
Dr. Aimee Wilkin

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.